icone plus 
	     
	    
	    
	    	
	
	
		
		
	
	     
	    
		
			
		 
		
			
		 
		
			
			
			
		 
		
			
				Contact Abonnez-vous aux actualités 
			 
		 
		
	 
 
     
    
   
  
  
	 
	 
	 
	 
	 
 
  
	 
	
		
			
			
			
				
  
    
  
	
    
        
            
            
                
                
                    
                    
                    
                    	
                    		
                    		
                    	
                    	
                    	
	                    
		                    
		                    	Technical information
		                    	
		                    
		                    
		                    
		                    	
		                    	
		                   
			                   
			                    	Presentation
			                    	
 
 
  
   TREMELIMUMAB ASTRAZENECA 20 mg/ml, solution à diluer pour perfusion
   
 
 
			                     
		                    
	                     
	                    
	                    
	                    
	
                	 
               	 
                
             
         
     
	
 
        
  
			
		
	 
	
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
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
BHwza5pqDuNyFbVW